Popular Reports / Immunology

---

This report is written by MaltSci based on the latest literature and research findings

---

How does immunometabolism regulate immune responses?

Abstract

Immunometabolism is an emerging field that explores the interplay between metabolic processes and immune responses, revealing how metabolic pathways influence immune cell behavior and functionality. This review provides a comprehensive overview of immunometabolism, highlighting its significance in regulating immune responses through metabolic reprogramming. Key metabolic pathways, including glycolysis, oxidative phosphorylation, and lipid metabolism, are discussed in relation to their roles in immune cell activation and differentiation. The review emphasizes that immune cells exhibit remarkable metabolic plasticity, allowing them to adapt to various environmental cues and functional demands. Importantly, metabolites produced during these metabolic processes serve as signaling molecules, modulating immune activity and influencing disease outcomes. Dysregulation of metabolic pathways has been linked to several conditions, including autoimmune diseases, cancer, and infections, underscoring the potential for therapeutic interventions targeting these pathways. The insights gained from this review not only enhance our understanding of immune cell biology but also pave the way for future research aimed at harnessing immunometabolic mechanisms for clinical benefit.

Outline

This report will discuss the following questions.

• 1 Introduction
• 2 Overview of Immunometabolism
  • 2.1 Definition and Scope of Immunometabolism
  • 2.2 Historical Context and Recent Advances
• 3 Metabolic Pathways in Immune Cells
  • 3.1 Glycolysis and Its Role in T Cell Activation
  • 3.2 Oxidative Phosphorylation in Macrophage Function
  • 3.3 Lipid Metabolism and Immune Cell Polarization
• 4 Metabolites as Signaling Molecules
  • 4.1 Role of Metabolites in Immune Signaling
  • 4.2 Impact of Metabolite Levels on Immune Responses
• 5 Immunometabolism in Disease Contexts
  • 5.1 Immunometabolism in Cancer
  • 5.2 Immunometabolism in Autoimmunity
  • 5.3 Immunometabolism in Infectious Diseases
• 6 Future Directions and Therapeutic Implications
  • 6.1 Potential Therapeutic Targets in Immunometabolism
  • 6.2 Challenges and Opportunities in Research
• 7 Summary

1 Introduction

Immunometabolism is an emerging and rapidly evolving field that investigates the intricate interplay between metabolic processes and immune system functions. The immune system, essential for protecting the host against pathogens, relies heavily on metabolic pathways to sustain its activity and adapt to various challenges. This dynamic relationship has garnered significant attention as researchers strive to elucidate how metabolic reprogramming within immune cells influences their activation, differentiation, and overall function. For instance, immune cells such as macrophages, T cells, and dendritic cells exhibit remarkable metabolic plasticity, allowing them to switch between different energy production pathways, such as glycolysis and oxidative phosphorylation, in response to environmental cues[1][2]. Understanding these metabolic adaptations is crucial, as they play a pivotal role in modulating immune responses and maintaining homeostasis within the organism[1].

The significance of immunometabolism extends beyond basic immunological research; it holds promising implications for therapeutic interventions across a range of diseases, including autoimmune disorders, cancer, and infectious diseases[3][4]. Recent studies have highlighted how dysregulated metabolic pathways can lead to aberrant immune cell behavior, contributing to disease pathogenesis. For example, alterations in glycolysis and lipid metabolism have been linked to the polarization of macrophages and the functional capacity of T cells during autoimmune responses[5][6]. Moreover, metabolites generated during these metabolic processes can act as signaling molecules that further influence immune cell functions, underscoring the bidirectional relationship between metabolism and immunity[7][8].

Current research in immunometabolism has made significant strides in elucidating the metabolic pathways involved in immune cell activation and differentiation. Glycolysis, oxidative phosphorylation, and lipid metabolism are now recognized as critical components that shape immune cell phenotypes and functions[3][9]. For instance, effector T cells rely on enhanced glycolytic activity to meet the energy demands of proliferation and effector functions during immune responses[5]. Additionally, the role of metabolites such as itaconate and succinate in regulating immune responses has gained prominence, highlighting the potential of targeting these pathways for therapeutic benefit[5][8].

The organization of this review will first provide an overview of immunometabolism, including its definition, scope, historical context, and recent advances. Following this, we will delve into the specific metabolic pathways involved in immune cell function, focusing on glycolysis in T cell activation, oxidative phosphorylation in macrophage function, and lipid metabolism in immune cell polarization. Subsequently, we will explore the role of metabolites as signaling molecules, examining how their levels impact immune responses. The review will also address the implications of immunometabolism in various disease contexts, including cancer, autoimmunity, and infectious diseases. Finally, we will discuss future directions and therapeutic implications, identifying potential targets for intervention and the challenges that lie ahead in this burgeoning field.

In conclusion, the integration of immunology and metabolism is proving to be a crucial frontier in understanding immune regulation. By dissecting the metabolic pathways that govern immune cell behavior, we aim to provide a comprehensive perspective on how immunometabolism shapes immune responses and offers novel therapeutic avenues for managing a range of diseases. The insights gained from this review will contribute to the growing body of knowledge in immunometabolism and pave the way for future research endeavors aimed at harnessing these mechanisms for clinical benefit.

2 Overview of Immunometabolism

2.1 Definition and Scope of Immunometabolism

Immunometabolism is an emerging field that investigates the intricate interplay between metabolic processes and immune responses, thereby playing a critical role in regulating immune system functionality and maintaining physiological homeostasis. It encompasses the study of how metabolic pathways influence immune cell behavior, including activation, differentiation, and function, and how these processes are affected by the microenvironment.

At its core, immunometabolism involves metabolic reprogramming of immune cells during their activation and differentiation. This reprogramming is mediated by complex signaling pathways that enable immune cells to adapt their metabolic processes according to their functional demands. For instance, during immune activation, T cells and macrophages may shift their metabolism towards increased glycolysis and oxidative phosphorylation to meet the heightened energy and biosynthetic needs associated with their effector functions[1][4][5].

The metabolic state of immune cells is influenced by various factors, including the availability of nutrients and the presence of metabolic products. For example, certain metabolites produced during metabolic pathways can act as signaling molecules that modulate immune responses. Itaconate, derived from the tricarboxylic acid (TCA) cycle, has been identified as a significant immunometabolite that inhibits pro-inflammatory cytokine production and influences T cell differentiation[5].

Furthermore, disruptions in immunometabolism can lead to pathological conditions. Abnormal metabolic regulation in immune cells has been implicated in the pathogenesis of autoimmune diseases, where altered activation and differentiation of immune cells can lead to tissue damage and chronic inflammation[4][5]. In diseases such as immune thrombocytopenia (ITP), metabolic abnormalities affecting glycolysis and fatty acid oxidation have been shown to influence immune cell behavior and disease progression[4].

Immunometabolism is not limited to immune activation; it also plays a vital role in immune tolerance and resolution of inflammation. Regulatory T cells (Tregs), for instance, rely on specific metabolic cues to maintain their anti-inflammatory functions and suppress excessive immune responses[2][6]. This highlights the importance of metabolic pathways in shaping the fate and function of various immune cell types.

In summary, immunometabolism serves as a fundamental regulatory mechanism that governs immune responses through metabolic reprogramming, signaling interactions, and adaptations to environmental cues. The insights gained from this field not only enhance our understanding of immune cell biology but also open new avenues for therapeutic interventions targeting metabolic pathways to modulate immune responses in various diseases, including autoimmunity, cancer, and infectious diseases[3][9].

2.2 Historical Context and Recent Advances

Immunometabolism refers to the intricate interplay between metabolic processes and immune responses, a concept that has gained significant attention in recent years. It encompasses the ways in which immune cells adapt their metabolic pathways in response to various stimuli, influencing their activation, differentiation, and overall function. The historical context of immunometabolism can be traced back to observations that inflammation and metabolic processes are closely linked, particularly in conditions such as obesity and autoimmune diseases.

Recent advances in the field have elucidated the critical role of metabolism in regulating immune responses. Immune cells, such as T cells and macrophages, undergo metabolic reprogramming to meet the energy demands required for their activation and function. For instance, during immune activation, T cells increase glycolysis to support rapid proliferation and effector functions, while macrophages may shift their metabolism towards fatty acid oxidation or glycolysis depending on their activation state[1][5].

Key metabolites produced during these metabolic processes, referred to as immunometabolites, have been shown to directly influence immune activity. For example, itaconate, a metabolite derived from the tricarboxylic acid (TCA) cycle, has been identified as a significant immunometabolite that modulates inflammation by inhibiting the NLRP3 inflammasome and reducing the production of pro-inflammatory cytokines such as IL-1β and IL-6[5][10]. This highlights the dual role of metabolites not only as energy sources but also as signaling molecules that fine-tune immune responses.

Moreover, the metabolic state of immune cells can affect their phenotypic characteristics and functions. For example, alterations in glycolysis and oxidative phosphorylation pathways have been implicated in the pathogenesis of various autoimmune diseases. In immune thrombocytopenia (ITP), metabolic dysfunction contributes to abnormal immune cell activation, which in turn exacerbates the disease[4]. Similarly, in the context of type 2 diabetes, inflammation driven by metabolic changes has been linked to impaired immune function[11].

The regulatory mechanisms governing immunometabolism involve complex signaling pathways that respond to environmental cues, including nutrient availability and inflammatory signals. Immune cells exhibit metabolic plasticity, allowing them to adapt their metabolism based on their microenvironment. This plasticity is crucial for maintaining immune homeostasis and preventing excessive inflammation[1][12].

In summary, immunometabolism plays a pivotal role in shaping immune responses through metabolic reprogramming and the action of immunometabolites. Understanding these processes provides insights into the underlying mechanisms of various diseases and opens avenues for therapeutic interventions targeting metabolic pathways in immune cells. As research in this field progresses, it is anticipated that more specific metabolic targets will be identified, offering potential strategies for treating autoimmune diseases, cancer, and other conditions influenced by immune dysregulation.

3 Metabolic Pathways in Immune Cells

3.1 Glycolysis and Its Role in T Cell Activation

Immunometabolism plays a critical role in regulating immune responses, particularly through the modulation of metabolic pathways such as glycolysis. Glycolysis is essential for the activation and effector functions of T cells, influencing their differentiation and overall immune activity.

Upon activation, T cells undergo significant metabolic reprogramming characterized by a shift from oxidative phosphorylation to increased glycolysis. This transition is vital for meeting the heightened energy demands associated with T cell proliferation and function during immune responses. Specifically, effector T cells rely heavily on glycolysis to generate ATP and produce metabolic intermediates that are crucial for biosynthetic processes, including the synthesis of nucleotides and amino acids required for rapid cell division and function (Noble et al., 2024) [13].

Furthermore, the metabolites generated during glycolysis not only provide energy but also serve as signaling molecules that modulate immune activity. For instance, the accumulation of lactate and other glycolytic byproducts can influence the inflammatory response and alter the activation status of various immune cells (Soto-Heredero et al., 2020) [14]. In the context of T cell activation, glycolytic intermediates can also participate in post-translational modifications of proteins, which may further affect T cell fate and function (Diskin et al., 2021) [15].

In addition to providing energy, glycolysis has been shown to regulate epigenetic changes within T cells. The availability of glycolytic metabolites can impact the expression of transcription factors that are crucial for T cell differentiation, such as enhancing the expression of Th17-associated genes while suppressing regulatory T cell markers (Tada & Kono, 2025) [5]. This interplay between metabolism and epigenetics highlights the complexity of T cell regulation and underscores the potential for targeting metabolic pathways as a therapeutic strategy in autoimmune diseases and cancer (Marchesi et al., 2020) [16].

Overall, the metabolic pathways utilized by T cells, particularly glycolysis, are pivotal in shaping their activation, differentiation, and function, thereby directly influencing immune responses. Understanding these metabolic mechanisms offers promising avenues for developing new immunotherapeutic strategies aimed at modulating immune responses in various pathological conditions.

3.2 Oxidative Phosphorylation in Macrophage Function

Immunometabolism plays a critical role in regulating immune responses, particularly through the modulation of metabolic pathways in immune cells such as macrophages. The metabolic state of these cells significantly influences their activation, differentiation, and overall function, thereby impacting both innate and adaptive immunity.

Macrophages exhibit plasticity in their metabolic responses, adopting different metabolic pathways depending on the environmental cues they receive. For instance, pro-inflammatory macrophages (M1) predominantly rely on glycolysis and the tricarboxylic acid (TCA) cycle to meet their energy demands during inflammatory responses. This metabolic shift supports their role in producing inflammatory cytokines and reactive oxygen species (ROS) necessary for pathogen defense. In contrast, anti-inflammatory macrophages (M2) utilize oxidative phosphorylation (OXPHOS) and fatty acid oxidation (FAO) to generate energy, which is essential for their role in tissue repair and resolution of inflammation [17][18].

Specifically, the TCA cycle and OXPHOS are intact in M2 macrophages, facilitating efficient energy production and redox balance. This metabolic configuration allows M2 macrophages to sustain prolonged survival and function effectively in tissue regeneration [17]. Conversely, in M1 macrophages, activation leads to impaired mitochondrial respiration and a disrupted TCA cycle, resulting in the accumulation of intermediates such as succinate and citrate. These metabolites can serve as signaling molecules that further modulate immune functions [19].

Recent research has highlighted the significance of metabolic reprogramming in macrophage activation and its implications for inflammatory diseases. For instance, in the context of obesity and type 2 diabetes, alterations in metabolic pathways, including those involving glucose and fatty acids, have been shown to influence macrophage polarization and inflammatory responses [20][21]. Understanding these metabolic pathways not only provides insights into the mechanisms underlying macrophage function but also presents potential therapeutic targets for modulating immune responses in various diseases.

Moreover, the interplay between metabolism and immune signaling is complex. For example, the activation of the NLRP3 inflammasome, which is crucial for the production of pro-inflammatory cytokines, is influenced by the metabolic state of macrophages. Metabolites such as itaconate, derived from the TCA cycle, can inhibit NLRP3 activation and thereby reduce inflammation [5]. This highlights how specific metabolic intermediates can directly impact immune responses.

In summary, the regulation of immune responses through immunometabolism is a multifaceted process that involves the dynamic interplay of various metabolic pathways, particularly oxidative phosphorylation and glycolysis, in macrophages. The understanding of these metabolic mechanisms is essential for developing new therapeutic strategies aimed at treating inflammatory and autoimmune diseases.

3.3 Lipid Metabolism and Immune Cell Polarization

Immunometabolism is a rapidly evolving field that investigates the intricate relationship between metabolic pathways and immune cell function, highlighting how metabolic reprogramming influences immune responses. A key aspect of this relationship is the role of lipid metabolism in shaping immune cell polarization and function.

Lipid metabolism encompasses various processes, including lipid uptake, de novo lipid synthesis, and fatty acid oxidation, which are critical for immune cell activation and differentiation. Myeloid cells, which play a pivotal role in bridging innate and adaptive immunity, exhibit significant changes in lipid metabolism during their activation. These metabolic alterations not only provide energy but also serve as structural components essential for the formation of cellular membranes and signaling molecules that influence immune responses [22].

Recent studies have shown that different immune cell subsets utilize distinct metabolic pathways to fulfill their functional roles. For instance, regulatory T cells primarily rely on oxidative phosphorylation and fatty acid oxidation, whereas effector CD8 T cells depend on glycolysis for their activation and effector functions [13]. This divergence in metabolic programming reflects how immune cells adapt to their environment and the specific demands of the immune response.

Furthermore, lipid metabolites, such as eicosanoids and cholesterol, have been identified as key modulators of immune responses. These metabolites can influence the differentiation and function of immune cells, thereby affecting the overall immune landscape. For example, alterations in lipid metabolism can lead to the modulation of macrophage polarization, which is crucial for determining whether the immune response is pro-inflammatory or anti-inflammatory [23].

The dysregulation of lipid metabolism has been implicated in various diseases, including autoimmune disorders and chronic inflammatory conditions. In such contexts, understanding the mechanisms by which lipids regulate immune cell function may offer novel therapeutic insights. For instance, targeting specific metabolic pathways that influence immune responses could provide new strategies to modulate the immune system in diseases characterized by inappropriate immune activation [24].

In summary, immunometabolism, particularly lipid metabolism, plays a critical role in regulating immune responses by influencing immune cell polarization and function. The distinct metabolic profiles of immune cell subsets allow for tailored responses to various stimuli, highlighting the potential for therapeutic interventions aimed at metabolic pathways to enhance or suppress immune responses in different disease contexts.

4 Metabolites as Signaling Molecules

4.1 Role of Metabolites in Immune Signaling

Immunometabolism refers to the interplay between metabolic processes and immune responses, wherein metabolites generated during cellular metabolism serve as crucial signaling molecules that influence immune cell function, activation, and differentiation. The regulation of immune responses through immunometabolism occurs via several mechanisms, primarily involving the modulation of metabolic pathways and the signaling functions of specific metabolites.

Metabolites such as lactate, succinate, itaconate, and β-hydroxybutyrate play significant roles in this regulatory framework. These metabolites can act as signaling molecules that link metabolic changes to immune responses, thereby influencing the behavior of various immune cell types. For instance, lactate, which accumulates under hypoxic conditions, has been identified as a major regulator of innate immunity. It interacts with specific sensors, such as AARS1 and AARS2, which catalyze lactylation of proteins like cGAS. This lactylation inhibits cGAS activity, thus modulating immune responses and balancing inflammation with immune tolerance [25].

Itaconate, a metabolite derived from the tricarboxylic acid (TCA) cycle, is produced by activated macrophages and has emerged as a critical immunometabolite. Itaconate inhibits the NLRP3 inflammasome and pro-inflammatory cytokines, including IL-1β and IL-6. Additionally, itaconate alters metabolic and epigenetic processes in T cells, reducing the levels of 2-hydroxyglutarate and modulating the SAM/SAH ratio, which suppresses Th17 differentiation while enhancing Foxp3 expression in regulatory T cells (Tregs). This dual action of itaconate not only ameliorates autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus but also exhibits antimicrobial properties [5].

Furthermore, the metabolic reprogramming of immune cells during activation is pivotal for their function. For example, effector T cells undergo significant metabolic shifts, characterized by increased glycolysis, to support their proliferation and functionality during immune responses. The integration of nutrient sensing with immune activation signals is essential for shaping T cell differentiation and sensitivity to metabolites [26]. Metabolites can serve as both signal propagators and unique signals influencing immune differentiation pathways, highlighting their role in the complex signaling networks that govern immune cell behavior [27].

Moreover, metabolites also facilitate communication between immune cells and their environment. Secreted immune metabolites (SIMets) play a crucial role in immune communication networks, fine-tuning immune responses in both homeostatic and pathological conditions. This suggests that the delivery of various metabolites into the local environment is essential for orchestrating immune responses [28].

The understanding of immunometabolism and the role of metabolites as signaling molecules has profound implications for therapeutic interventions in various diseases, including cancer, autoimmunity, and metabolic disorders. By targeting specific metabolic pathways or the signaling functions of metabolites, it may be possible to restore or modulate immune function, providing new avenues for treatment [29].

In summary, immunometabolism regulates immune responses through the signaling functions of metabolites, which influence the activation, differentiation, and function of immune cells. The intricate relationship between metabolism and immune signaling underscores the potential for harnessing these mechanisms in therapeutic contexts.

4.2 Impact of Metabolite Levels on Immune Responses

Immunometabolism is increasingly recognized as a crucial regulator of immune responses, particularly through the action of metabolites as signaling molecules. The interplay between cellular metabolism and immune function is essential for the activation, differentiation, and overall functionality of immune cells. Metabolites, which are the byproducts of metabolic pathways, serve dual roles: they not only provide energy and building blocks for cell proliferation but also act as signaling molecules that modulate immune activity.

Recent studies have highlighted how specific metabolites influence immune responses. For instance, itaconate, a metabolite derived from the tricarboxylic acid (TCA) cycle, is produced in activated macrophages and has been shown to inhibit the NLRP3 inflammasome and pro-inflammatory cytokines such as IL-1β and IL-6. This suggests that itaconate plays a significant role in controlling inflammation, thus impacting the progression of autoimmune diseases like rheumatoid arthritis and systemic lupus erythematosus [5]. Moreover, itaconate has demonstrated therapeutic potential in ameliorating conditions such as experimental autoimmune encephalomyelitis and has antimicrobial properties, indicating its broad influence on immune responses [30].

Furthermore, lactate has emerged as a critical metabolite in regulating innate immunity. Under hypoxic conditions, lactate levels increase and interact with specific metabolite sensors, such as AARS1 and AARS2, which catalyze lactylation of proteins involved in immune signaling. For example, the lactylation of cGAS, a key player in DNA sensing, modulates its activity, thereby influencing the balance between inflammation and immune tolerance [25]. This demonstrates how metabolite levels can dictate immune responses through post-translational modifications and signaling pathways.

In addition to itaconate and lactate, other metabolites like succinate and kynurenine also play significant roles in shaping immune responses. Succinate accumulates during inflammation and can activate the succinate receptor, which influences macrophage polarization and promotes pro-inflammatory responses [8]. Kynurenine, derived from tryptophan metabolism, has been shown to modulate T cell responses and contribute to immune tolerance [31].

The regulation of immune responses by metabolites is not limited to their accumulation; the context in which these metabolites are produced and their subsequent signaling effects are critical. For instance, during viral infections, the metabolic landscape shifts towards increased aerobic glycolysis, which supports the energy demands of immune cells and facilitates their activation [31]. This metabolic reprogramming is vital for effective immune responses against pathogens.

In summary, immunometabolism plays a fundamental role in regulating immune responses through metabolites that serve as signaling molecules. The levels of these metabolites, influenced by metabolic pathways and cellular environments, significantly impact the activation, differentiation, and function of immune cells. Understanding these interactions opens new avenues for therapeutic interventions targeting metabolic pathways to modulate immune responses in various diseases, including autoimmunity and cancer [5][25][31].

5 Immunometabolism in Disease Contexts

5.1 Immunometabolism in Cancer

Immunometabolism plays a pivotal role in regulating immune responses, particularly in the context of cancer. The intricate interplay between the metabolic pathways of immune cells and cancer cells significantly influences the effectiveness of the immune response against tumors.

Cancer cells often undergo metabolic reprogramming to support their rapid proliferation and survival, which can alter the tumor microenvironment (TME) and impact immune cell functionality. For instance, cancer metabolism is not only essential for sustaining carcinogenesis but also modulates immune cell function through mechanisms such as nutrient competition and metabolic byproducts. This competition for nutrients can lead to a state of metabolic stress in immune cells, impairing their ability to mount effective antitumor responses [32].

In the TME, factors such as hypoxia and acidosis further complicate immune responses. Tumor cells can produce metabolites like lactate, which contribute to an immunosuppressive environment, inhibiting the activation and proliferation of immune cells, including T cells and macrophages [33]. This metabolic reprogramming in immune cells is critical for their proliferation, differentiation, and effector functions, and it is becoming increasingly clear that the metabolic status of immune cells directly influences their ability to combat tumors [34].

Moreover, specific immune cell types adapt their metabolic pathways in response to the TME. For example, B cells and T cells exhibit unique metabolic profiles that determine their fate and functionality within the tumor context. The TME not only alters the metabolic behavior of these immune cells but also affects their interactions with cancer cells, which can either promote or inhibit antitumor immunity [35].

Recent research emphasizes the importance of targeting metabolic pathways as a therapeutic strategy in cancer immunotherapy. By enhancing the metabolic fitness of immune cells or disrupting the metabolic advantages of cancer cells, it may be possible to improve the efficacy of existing immunotherapies [36]. Additionally, interventions that modify systemic metabolism, such as dietary changes, could also enhance the immune response to cancer [37].

In summary, immunometabolism serves as a crucial regulatory mechanism that shapes immune responses in cancer. Understanding the metabolic crosstalk between cancer and immune cells is essential for developing innovative strategies aimed at enhancing antitumor immunity and improving cancer treatment outcomes. This evolving field holds promise for the discovery of novel therapeutic targets and the advancement of precision medicine in oncology [38][39].

5.2 Immunometabolism in Autoimmunity

Immunometabolism is a critical area of research that explores the interplay between metabolic processes and immune responses, particularly in the context of autoimmune diseases. This field has emerged from the understanding that immune cell metabolism is not merely a background process but actively regulates immune functions, including activation, differentiation, and effector functions.

In autoimmune diseases, such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), dysregulation of immune cell metabolism can lead to aberrant immune responses. Immune cells, including T cells and B cells, undergo metabolic reprogramming to meet the demands of their activation and function. For instance, effector T cells often shift towards increased glycolysis to support their rapid proliferation and function during autoimmune responses [5]. This metabolic shift is essential for the production of energy and key intermediates required for cell growth and proliferation.

Recent research highlights the role of specific metabolites, termed immunometabolites, in modulating immune responses. These metabolites can be generated intracellularly or secreted into the extracellular environment, where they influence the behavior of immune cells. A notable example is itaconate, derived from the TCA cycle by aconitate decarboxylase 1 (ACOD1) in activated macrophages. Itaconate has been shown to inhibit the NLRP3 inflammasome and pro-inflammatory cytokines such as IL-1β and IL-6, thus exerting an anti-inflammatory effect [5]. Additionally, itaconate alters metabolic and epigenetic processes in T cells, promoting regulatory T cell (Treg) functions while suppressing Th17 differentiation [5].

The disruption of normal metabolic pathways can contribute to the pathogenesis of autoimmune diseases. For example, in immune thrombocytopenia (ITP), metabolic abnormalities are linked to abnormal activation and differentiation of immune cells, leading to self-tissue attacks [4]. Furthermore, studies indicate that mitochondrial dysfunction is a common feature in various autoimmune conditions, which affects immune cell differentiation and contributes to chronic inflammation [40].

The concept of immunometabolism extends to therapeutic implications as well. Targeting metabolic pathways or introducing anti-inflammatory metabolites like itaconate presents novel therapeutic strategies for managing autoimmune diseases [41]. This approach aims to restore metabolic balance in immune cells, potentially ameliorating the pathological immune responses characteristic of autoimmune disorders [42].

Overall, the regulation of immune responses through immunometabolism highlights the intricate relationship between metabolic processes and immune functions, suggesting that metabolic interventions could be a promising avenue for therapeutic development in autoimmune diseases. Understanding these mechanisms not only provides insights into disease pathogenesis but also opens up new possibilities for treatment strategies aimed at restoring immune homeostasis.

5.3 Immunometabolism in Infectious Diseases

Immunometabolism plays a crucial role in regulating immune responses, particularly in the context of infectious diseases. This regulation is characterized by the interplay between metabolic processes and immune cell functions, influencing both the activation and polarization of immune responses.

Upon encountering pathogens, immune cells undergo significant metabolic reprogramming. This process is marked by a shift from oxidative phosphorylation to aerobic glycolysis, which enhances the production of pro-inflammatory cytokines and supports the energy demands of activated immune cells. For instance, during viral infections, the metabolic landscape of host cells is altered to facilitate an effective antiviral response. Increased nutrient availability is vital for the proliferation and function of immune cells, allowing for a robust defense against pathogens [31].

The mitochondrial enzyme aconitate decarboxylase 1 (ACOD1), also known as immunoresponsive gene 1 (IRG1), is a key player in this metabolic regulation. It is upregulated in various inflammatory conditions and is involved in the production of itaconate, a metabolite that modulates macrophage polarization and inflammasome activation. The ACOD1-itaconate pathway is particularly significant in the context of sepsis and septic shock, where dysregulated host responses to infection can lead to life-threatening organ failure [12].

Immunometabolites, which include small molecules such as succinate and itaconate, act as critical mediators in the immune response. These metabolites not only serve as energy sources but also influence the activation and differentiation of immune cells. For example, succinate can stabilize hypoxia-inducible factor-1α (HIF-1α), promoting the production of interleukin-1β through inflammasome activation, thus driving inflammation [43].

Furthermore, the concept of immunometabolism extends to the impact of metabolic pathways on the fate of immune cells during infections. The metabolic adaptations that occur upon viral recognition are essential for determining the course of the infection and the subsequent immune response. For instance, alterations in glucose and fatty acid metabolism can significantly affect the behavior of immune cells, leading to enhanced or suppressed inflammatory responses [44].

In summary, immunometabolism regulates immune responses through a dynamic interplay between metabolic pathways and immune cell functions. This regulation is vital for the effective control of infections, highlighting the potential for therapeutic strategies that target metabolic processes to enhance immune responses during infectious diseases. The exploration of immunometabolism offers promising avenues for developing interventions that could modulate immune responses to improve outcomes in infectious disease contexts [3][4].

6 Future Directions and Therapeutic Implications

6.1 Potential Therapeutic Targets in Immunometabolism

Immunometabolism represents a critical intersection between metabolic processes and immune responses, significantly influencing the regulation of immunity in both health and disease. The regulation of immune responses through immunometabolism involves various metabolic pathways that shape the function, activation, and differentiation of immune cells.

The concept of immunometabolism encompasses the idea that metabolic pathways are not merely energy-generating systems but also play essential roles in signaling and controlling immune functions. For instance, different immune cell populations, such as effector T cells and regulatory T cells, have distinct metabolic requirements that dictate their functional outcomes. This selectivity allows for tailored immune responses based on the metabolic state of the immune cells involved [45].

Moreover, the role of gut microbes in modulating immune cell metabolism is noteworthy. Gut microbiota can influence immune cell metabolic profiles and functional responses through the production of metabolites that engage in crosstalk with intestinal epithelial cells and mucosal immune cells. This interaction suggests that targeting metabolic pathways in mucosal immune cells could lead to innovative therapeutic strategies for autoimmune and inflammatory diseases, including inflammatory bowel disease [45].

In terms of future directions, the exploration of immunometabolism opens avenues for targeted therapies that manipulate metabolic pathways to enhance or suppress immune responses. For example, in autoimmune diseases like immune thrombocytopenia (ITP), metabolic dysfunction has been linked to abnormal immune cell activation and differentiation. This suggests that therapeutic strategies could be developed to correct metabolic abnormalities, thereby restoring normal immune function [4].

Potential therapeutic targets in immunometabolism include key metabolic pathways involved in glycolysis, fatty acid oxidation, and amino acid metabolism, which have been shown to influence immune cell behavior and disease progression. For instance, metabolic reprogramming of immune cells can enhance antitumor immune responses, indicating that metabolic interventions may serve as a viable strategy in cancer immunotherapy [36]. Furthermore, pharmacological agents that target specific metabolic events, such as DMF, Metformin, Methotrexate, and Rapamycin, have shown promise in limiting inflammation and modifying immune responses [46].

In summary, immunometabolism serves as a fundamental mechanism regulating immune responses, offering potential therapeutic targets that can be harnessed to develop novel interventions for various diseases, including autoimmune disorders, cancer, and metabolic syndromes. As research in this field advances, the integration of metabolic insights into clinical practice could lead to personalized medicine approaches that enhance immune function and improve patient outcomes [3][47].

6.2 Challenges and Opportunities in Research

Immunometabolism is a rapidly evolving field that elucidates the interplay between metabolic processes and immune cell functions, significantly influencing immune responses. The regulation of immune responses by immunometabolism occurs through various mechanisms, including metabolic reprogramming, nutrient availability, and the interaction of immune cells with their microenvironment.

Immune cells, such as T cells and macrophages, exhibit distinct metabolic pathways that correlate with their functional states. For instance, pro-inflammatory immune cells often rely on glycolysis and glutamine oxidation for energy, while anti-inflammatory regulatory T cells predominantly utilize fatty acid oxidation [48]. This metabolic heterogeneity allows immune cells to adapt their functions based on the local microenvironment and the nature of the immune challenge they face. The metabolic status of these cells can dictate their activation, proliferation, and differentiation, ultimately shaping the overall immune response [4].

Moreover, metabolic products and intermediates play critical roles in modulating immune responses. For example, metabolites such as succinate and itaconate have been identified as key immunometabolites that influence immune cell activation and function [8]. These metabolites can either promote or inhibit inflammatory responses, highlighting their potential as therapeutic targets.

Future directions in immunometabolism research involve leveraging advanced technologies to gain deeper insights into metabolic regulation within immune cells. Techniques such as single-cell metabolomics and spatial tissue profiling are expected to enhance our understanding of how metabolic pathways are altered in various disease contexts, including cancer, autoimmune diseases, and metabolic disorders [6]. The identification of novel metabolic biomarkers and the application of metabolomics-driven personalized medicine are also anticipated to revolutionize cancer diagnosis and treatment [36].

However, the field faces several challenges. One significant hurdle is the complexity of metabolic pathways and their regulation within diverse immune cell populations. Understanding the intricate crosstalk between metabolism and immune signaling pathways remains a daunting task [49]. Additionally, translating findings from preclinical studies to clinical applications poses challenges, particularly in establishing effective therapeutic strategies that target metabolic pathways without compromising immune homeostasis [3].

Despite these challenges, the opportunities in immunometabolism research are vast. By unraveling the mechanisms underlying metabolic regulation of immune responses, researchers can identify new therapeutic targets for a range of diseases. Targeting immunometabolic pathways holds promise for developing innovative treatments that can enhance antitumor immunity, improve outcomes in autoimmune diseases, and mitigate the effects of metabolic disorders [50]. The ongoing exploration of immunometabolism is likely to yield significant insights that will inform future therapeutic strategies and clinical interventions.

7 Conclusion

The field of immunometabolism has emerged as a crucial area of research, revealing the intricate relationship between metabolic processes and immune responses. This review highlights the significant findings regarding how metabolic pathways, including glycolysis, oxidative phosphorylation, and lipid metabolism, regulate immune cell activation, differentiation, and function. Key discoveries demonstrate that metabolic reprogramming is essential for the proper functioning of immune cells, with specific metabolites acting as signaling molecules that influence immune activity. Current research underscores the importance of understanding these metabolic adaptations, particularly in the context of diseases such as cancer, autoimmunity, and infections. Future directions in this field should focus on identifying novel therapeutic targets within metabolic pathways to modulate immune responses effectively. By harnessing the insights gained from immunometabolism, there is potential for the development of innovative therapies that can enhance immune function and improve clinical outcomes across a spectrum of diseases.

References

• [1] Rongrong Xu;Xiaobo He;Jia Xu;Ganjun Yu;Yanfeng Wu. Immunometabolism: signaling pathways, homeostasis, and therapeutic targets.. MedComm(IF=10.7). 2024. PMID:39492834. DOI: 10.1002/mco2.789.
• [2] Frédérique Savagner;Thomas Farge;Zoubida Karim;Meryem Aloulou. Iron and energy metabolic interactions in Treg-mediated immune regulation.. Frontiers in immunology(IF=5.9). 2025. PMID:40176804. DOI: 10.3389/fimmu.2025.1554028.
• [3] Tengyue Hu;Chang-Hai Liu;Min Lei;Qingmin Zeng;Li Li;Hong Tang;Nannan Zhang. Metabolic regulation of the immune system in health and diseases: mechanisms and interventions.. Signal transduction and targeted therapy(IF=52.7). 2024. PMID:39379377. DOI: 10.1038/s41392-024-01954-6.
• [4] Xin Zhou;Ning-Ning Shan. The metabolism-immunity axis in Immune thrombocytopenia: from energy regulation to targeted therapy.. Pharmacological research(IF=10.5). 2025. PMID:40441458. DOI: 10.1016/j.phrs.2025.107803.
• [5] Maria Tada;Michihito Kono. Metabolites as regulators of autoimmune diseases.. Frontiers in immunology(IF=5.9). 2025. PMID:40918103. DOI: 10.3389/fimmu.2025.1637436.
• [6] Yi-Hao Wang;Limei Wang;Ping-Chih Ho. Decoding immunometabolism with next-generation tools: lessons from dendritic cells and T cells.. The EMBO journal(IF=8.3). 2025. PMID:40957982. DOI: 10.1038/s44318-025-00569-z.
• [7] Shadab Kazmi;Mohammad Afzal Khan;Talal Shamma;Abdullah Altuhami;Abdullah Mohammed Assiri;Dieter Clemens Broering. Therapeutic nexus of T cell immunometabolism in improving transplantation immunotherapy.. International immunopharmacology(IF=4.7). 2022. PMID:35189469. DOI: 10.1016/j.intimp.2022.108621.
• [8] Dylan Gerard Ryan;Christian Graham Peace;Alexander Hooftman. Basic Mechanisms of Immunometabolites in Shaping the Immune Response.. Journal of innate immunity(IF=3.0). 2023. PMID:37995666. DOI: 10.1159/000535452.
• [9] Edward B Thorp;Anja Karlstaedt. Intersection of Immunology and Metabolism in Myocardial Disease.. Circulation research(IF=16.2). 2024. PMID:38843291. DOI: 10.1161/CIRCRESAHA.124.323660.
• [10] Jian Tan;Duan Ni;Rosilene V Ribeiro;Gabriela V Pinget;Laurence Macia. How Changes in the Nutritional Landscape Shape Gut Immunometabolism.. Nutrients(IF=5.0). 2021. PMID:33801480. DOI: 10.3390/nu13030823.
• [11] Erika Pinheiro-Machado;Ewa Gurgul-Convey;Michal T Marzec. Immunometabolism in type 2 diabetes mellitus: tissue-specific interactions.. Archives of medical science : AMS(IF=3.3). 2023. PMID:37560741. DOI: 10.5114/aoms.2020.92674.
• [12] Runliu Wu;Rui Kang;Daolin Tang. Mitochondrial ACOD1/IRG1 in infection and sterile inflammation.. Journal of intensive medicine(IF=3.3). 2022. PMID:36789185. DOI: 10.1016/j.jointm.2022.01.001.
• [13] Johan Noble;Zuzana Macek Jilkova;Caroline Aspord;Paolo Malvezzi;Miguel Fribourg;Leonardo V Riella;Paolo Cravedi. Harnessing Immune Cell Metabolism to Modulate Alloresponse in Transplantation.. Transplant international : official journal of the European Society for Organ Transplantation(IF=3.0). 2024. PMID:38567143. DOI: 10.3389/ti.2024.12330.
• [14] Gonzalo Soto-Heredero;Manuel M Gómez de Las Heras;Enrique Gabandé-Rodríguez;Jorge Oller;María Mittelbrunn. Glycolysis - a key player in the inflammatory response.. The FEBS journal(IF=4.2). 2020. PMID:32255251. DOI: 10.1111/febs.15327.
• [15] C Diskin;T A J Ryan;L A J O'Neill. Modification of Proteins by Metabolites in Immunity.. Immunity(IF=26.3). 2021. PMID:33220233. DOI: 10.1016/j.immuni.2020.09.014.
• [16] Federica Marchesi;Debora Vignali;Beatrice Manini;Alessandra Rigamonti;Paolo Monti. Manipulation of Glucose Availability to Boost Cancer Immunotherapies.. Cancers(IF=4.4). 2020. PMID:33053779. DOI: 10.3390/cancers12102940.
• [17] Hongbo Ma;Limei Gao;Rong Chang;Lihong Zhai;Yanli Zhao. Crosstalk between macrophages and immunometabolism and their potential roles in tissue repair and regeneration.. Heliyon(IF=3.6). 2024. PMID:39381218. DOI: 10.1016/j.heliyon.2024.e38018.
• [18] Karen Pomeyie;Francis Abrokwah;Daniel Boison;Benjamin Amoani;Foster Kyei;Cynthia A Adinortey;Prince Amoah Barnie. Macrophage immunometabolism dysregulation and inflammatory disorders.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie(IF=7.5). 2025. PMID:40378771. DOI: 10.1016/j.biopha.2025.118142.
• [19] Evanna L Mills;Luke A O'Neill. Reprogramming mitochondrial metabolism in macrophages as an anti-inflammatory signal.. European journal of immunology(IF=3.7). 2016. PMID:26643360. DOI: 10.1002/eji.201445427.
• [20] Dorcus Makassy;Kyra Williams;Qutuba G Karwi. The Evolving Role of Macrophage Metabolic Reprogramming in Obesity.. The Canadian journal of cardiology(IF=5.3). 2025. PMID:40311669. DOI: 10.1016/j.cjca.2025.04.017.
• [21] Angela Wong;Qiuyu Sun;Ismail Ibrahim Latif;Qutuba G Karwi. Metabolic flux in macrophages in obesity and type-2 diabetes.. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques(IF=4.3). 2024. PMID:38988822. DOI: 10.3389/jpps.2024.13210.
• [22] Ayaka Ito;Takayoshi Suganami. Lipid metabolism in myeloid cell function and chronic inflammatory diseases.. Frontiers in immunology(IF=5.9). 2024. PMID:39911578. DOI: 10.3389/fimmu.2024.1495853.
• [23] Shane M O'Carroll;Fiona D R Henkel;Luke A J O'Neill. Metabolic regulation of type I interferon production.. Immunological reviews(IF=8.3). 2024. PMID:38465724. DOI: 10.1111/imr.13318.
• [24] Leila Mohammadnezhad;Mojtaba Shekarkar Azgomi;Marco Pio La Manna;Guido Sireci;Chiara Rizzo;Giusto Davide Badami;Bartolo Tamburini;Francesco Dieli;Giuliana Guggino;Nadia Caccamo. Metabolic Reprogramming of Innate Immune Cells as a Possible Source of New Therapeutic Approaches in Autoimmunity.. Cells(IF=5.2). 2022. PMID:35626700. DOI: 10.3390/cells11101663.
• [25] Qiqing Yang;Ce Guo;Long Zhang. The role of metabolite sensors in metabolism-immune interaction: New targets for immune modulation.. Clinical and translational medicine(IF=6.8). 2025. PMID:40159576. DOI: 10.1002/ctm2.70294.
• [26] Drew Wilfahrt;Greg M Delgoffe. Metabolic waypoints during T cell differentiation.. Nature immunology(IF=27.6). 2024. PMID:38238609. DOI: 10.1038/s41590-023-01733-5.
• [27] Agnieszka M Kabat;Erika L Pearce;Edward J Pearce. Metabolism in type 2 immune responses.. Immunity(IF=26.3). 2023. PMID:37044062. DOI: 10.1016/j.immuni.2023.03.007.
• [28] Baihao Zhang;Alexis Vogelzang;Sidonia Fagarasan. Secreted immune metabolites that mediate immune cell communication and function.. Trends in immunology(IF=13.9). 2022. PMID:36347788. DOI: 10.1016/j.it.2022.10.006.
• [29] Liza Makowski;Mehdi Chaib;Jeffrey C Rathmell. Immunometabolism: From basic mechanisms to translation.. Immunological reviews(IF=8.3). 2020. PMID:32320073. DOI: 10.1111/imr.12858.
• [30] Dan Ye;Pu Wang;Lei-Lei Chen;Kun-Liang Guan;Yue Xiong. Itaconate in host inflammation and defense.. Trends in endocrinology and metabolism: TEM(IF=12.6). 2024. PMID:38448252. DOI: 10.1016/j.tem.2024.02.004.
• [31] Behnaz Bouzari;Uliana Y Chugaeva;Sajad Karampoor;Rasoul Mirzaei. Immunometabolites in viral infections: Action mechanism and function.. Journal of medical virology(IF=4.6). 2024. PMID:39037069. DOI: 10.1002/jmv.29807.
• [32] Jean-Ehrland Ricci. Tumor-induced metabolic immunosuppression: Mechanisms and therapeutic targets.. Cell reports(IF=6.9). 2025. PMID:39798090. DOI: 10.1016/j.celrep.2024.115206.
• [33] Theodora Katopodi;Savvas Petanidis;Doxakis Anestakis;Charalampos Charalampidis;Ioanna Chatziprodromidou;George Floros;Panagiotis Eskitzis;Paul Zarogoulidis;Charilaos Koulouris;Christina Sevva;Konstantinos Papadopoulos;Marios Dagher;Vasileios Alexandros Karakousis;Nikolaos Varsamis;Vasiliki Theodorou;Chrysi Maria Mystakidou;Konstantinos Vlassopoulos;Stylianos Kosmidis;Nikolaos Iason Katsios;Konstantinos Farmakis;Christoforos Kosmidis. Tumor cell metabolic reprogramming and hypoxic immunosuppression: driving carcinogenesis to metastatic colonization.. Frontiers in immunology(IF=5.9). 2023. PMID:38292487. DOI: 10.3389/fimmu.2023.1325360.
• [34] Mingxia Jiang;Huapan Fang;Huayu Tian. Metabolism of cancer cells and immune cells in the initiation, progression, and metastasis of cancer.. Theranostics(IF=13.3). 2025. PMID:39744225. DOI: 10.7150/thno.103376.
• [35] Su Jiang;Ranran Feng;Ziying Tian;Jieyu Zhou;Wenling Zhang. Metabolic dialogs between B cells and the tumor microenvironment: Implications for anticancer immunity.. Cancer letters(IF=10.1). 2023. PMID:36724837. DOI: 10.1016/j.canlet.2023.216076.
• [36] Huiru Zhang;Jialiang Fan;Deyang Kong;Yu Sun;Qi Zhang;Renshen Xiang;Shuaibing Lu;Wenjing Yang;Lin Feng;Haizeng Zhang. Immunometabolism: crosstalk with tumor metabolism and implications for cancer immunotherapy.. Molecular cancer(IF=33.9). 2025. PMID:41063213. DOI: 10.1186/s12943-025-02460-1.
• [37] Andrea L Cote;Chad J Munger;Alison E Ringel. Emerging insights into the impact of systemic metabolic changes on tumor-immune interactions.. Cell reports(IF=6.9). 2025. PMID:39862435. DOI: 10.1016/j.celrep.2025.115234.
• [38] Gloria Pascual;Salvador Aznar Benitah. Lipids in the tumor microenvironment: immune modulation and metastasis.. Frontiers in oncology(IF=3.3). 2024. PMID:39391242. DOI: 10.3389/fonc.2024.1435480.
• [39] Robert D Leone;Jonathan D Powell. Fueling the Revolution: Targeting Metabolism to Enhance Immunotherapy.. Cancer immunology research(IF=8.2). 2021. PMID:33648947. DOI: 10.1158/2326-6066.CIR-20-0791.
• [40] Chun-Ting J Kwong;Mariana J Kaplan. Mitochondrial dysfunction in myeloid cells: a central deficit in autoimmune diseases.. Trends in immunology(IF=13.9). 2025. PMID:40930904. DOI: 10.1016/j.it.2025.08.003.
• [41] Ryo Hisada;Michihito Kono. Recent advances in immunometabolism in rheumatic diseases.. Current opinion in rheumatology(IF=4.3). 2025. PMID:39513377. DOI: 10.1097/BOR.0000000000001071.
• [42] Yue Chen;Qingqing Lin;Hui Cheng;Qiyu Xiang;Wenxian Zhou;Jinyu Wu;Xiaobing Wang. Immunometabolic shifts in autoimmune disease: Mechanisms and pathophysiological implications.. Autoimmunity reviews(IF=8.3). 2025. PMID:39743123. DOI: 10.1016/j.autrev.2024.103738.
• [43] Jonathan R Erlich;Eunice E To;Stella Liong;Robert Brooks;Ross Vlahos;John J O'Leary;Doug A Brooks;Stavros Selemidis. Targeting Evolutionary Conserved Oxidative Stress and Immunometabolic Pathways for the Treatment of Respiratory Infectious Diseases.. Antioxidants & redox signaling(IF=6.1). 2020. PMID:32008371. DOI: 10.1089/ars.2020.8028.
• [44] Clovis S Palmer. Innate metabolic responses against viral infections.. Nature metabolism(IF=20.8). 2022. PMID:36266542. DOI: 10.1038/s42255-022-00652-3.
• [45] Margret Michaels;Karen L Madsen. Immunometabolism and microbial metabolites at the gut barrier: Lessons for therapeutic intervention in inflammatory bowel disease.. Mucosal immunology(IF=7.6). 2023. PMID:36642380. DOI: 10.1016/j.mucimm.2022.11.001.
• [46] Eva M Pålsson-McDermott;Luke A J O'Neill. Targeting immunometabolism as an anti-inflammatory strategy.. Cell research(IF=25.9). 2020. PMID:32132672. DOI: 10.1038/s41422-020-0291-z.
• [47] Qin Dang;Borui Li;Bing Jin;Zeng Ye;Xin Lou;Ting Wang;Yan Wang;Xuan Pan;Qiangsheng Hu;Zheng Li;Shunrong Ji;Chenjie Zhou;Xianjun Yu;Yi Qin;Xiaowu Xu. Cancer immunometabolism: advent, challenges, and perspective.. Molecular cancer(IF=33.9). 2024. PMID:38581001. DOI: 10.1186/s12943-024-01981-5.
• [48] Naoki Tanimine;Laurence A Turka;Bhavana Priyadharshini. Navigating T-Cell Immunometabolism in Transplantation.. Transplantation(IF=5.0). 2018. PMID:28930796. DOI: 10.1097/TP.0000000000001951.
• [49] Wei-Chun Chou;Elena Rampanelli;Xin Li;Jenny P-Y Ting. Impact of intracellular innate immune receptors on immunometabolism.. Cellular & molecular immunology(IF=19.8). 2022. PMID:34697412. DOI: 10.1038/s41423-021-00780-y.
• [50] Lixiang Feng;Xingyu Chen;Yujing Huang;Xiaodian Zhang;Shaojiang Zheng;Na Xie. Immunometabolism changes in fibrosis: from mechanisms to therapeutic strategies.. Frontiers in pharmacology(IF=4.8). 2023. PMID:37576819. DOI: 10.3389/fphar.2023.1243675.

MaltSci Intelligent Research Services

Create Your Professional Reports Easily

---

© 2025 MaltSci